Analyst Research Report Snapshot

Title:

Comba Telecom (2342 HK, HK$2.76, OP): Initiate coverage with Outperform

Price:

$92.00

Provider:

KGI Greater China

Date:

05 Dec 2013

Pages:

9

Type:

AcrobatPDF

Companies referenced:

2342.HK

Available for Immediate Download
Summary:

4G/LTE launch in China a boost 1H13 results poor on structural changes on Chinese telecom capex Comba Telecom reported 1H13 (FY ends December) revenue of HK$2.2bn and a net loss of HK$151mn, down 16% and flat YoY, respectively. Chinese mobile carriers are cutting capex on GSM and 4G/LTE capex has stalled, resulting in poor short-term visibility for telecom equipment makers. Though 4G/LTE licenses will be issued soon, Comba Telecom may not benefit until after 1Q14 given the late cycle nature of its business. 4G/LTE launch delay or capex reduction biggest risks to our thesis Comba Telecom has invested significant R&D resources in developing new product lines like small cells but has yet to turn any of the China Mobile provincial trials into contracts. Other near-term risks include below guidance capex spending from China Unicom, rising receivables on slower payment terms, and poor cost controls. Low baseline with 27.7% upside potential – Initiate with Outperform 2013 has set a low baseline for Comba Telecom. As capex from Chinese telecoms kicks in, we will see revenue start to pick up in 2014 and normalize by 2015. We believe now is a good time to accumulate shares. We initiate coverage of Comba with Outperform.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.